When will vortioxetine be generic?

Vortioxetine Generic Availability Timeline

Vortioxetine, also known as Brintellix, is a medication for treating depressive disorders. The patent for vortioxetine was set to expire in 2025 [1] (https://www.drugpatentwatch.com/). However, the exact generic availability date may be influenced by factors such as FDA approval, regulatory hurdles, and manufacturer decisions.

When Will Vortioxetine's Patent Expire?

According to DrugPatentWatch.com, the patent for vortioxetine is set to expire in March 2025 in the US [1]. After this date, generic versions of the medication may become available, and the patent expiration could lead to increased competition in the market, potentially driving down prices.

Current Generic Options

As of now, no generic versions of vortioxetine are approved by the FDA, and the medication remains under patent exclusivity. However, it's essential to note that generic versions might become available in the months following the patent expiration date.

Impact on Vortioxetine Prices

Genericization of vortioxetine could lead to reduced prices and improved patient access to the medication. However, the pricing dynamics of the generic market are complex and subject to various factors, including manufacturer competition, production costs, and regulatory oversight.

References

[1] DrugPatentWatch.com - (https://www.drugpatentwatch.com/)

Sources Citied

1. DrugPatentWatch.com (https://www.drugpatentwatch.com/)